The absence of TRPS1 expression in ER− BCC lines could be related to its significant down-regulation in ER− breast cancer samples; however, this finding needs to be validated in a wider number of ER− BCC lines and by quantitative immunohistochemistry analysis. This evidence concerns the gene TRPS1 and breast carcinoma.